Cargando…
Automated Tubule Nuclei Quantification and Correlation with Oncotype DX risk categories in ER+ Breast Cancer Whole Slide Images
Early stage estrogen receptor positive (ER+) breast cancer (BCa) treatment is based on the presumed aggressiveness and likelihood of cancer recurrence. Oncotype DX (ODX) and other gene expression tests have allowed for distinguishing the more aggressive ER+ BCa requiring adjuvant chemotherapy from t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013328/ https://www.ncbi.nlm.nih.gov/pubmed/27599752 http://dx.doi.org/10.1038/srep32706 |
_version_ | 1782452141336559616 |
---|---|
author | Romo-Bucheli, David Janowczyk, Andrew Gilmore, Hannah Romero, Eduardo Madabhushi, Anant |
author_facet | Romo-Bucheli, David Janowczyk, Andrew Gilmore, Hannah Romero, Eduardo Madabhushi, Anant |
author_sort | Romo-Bucheli, David |
collection | PubMed |
description | Early stage estrogen receptor positive (ER+) breast cancer (BCa) treatment is based on the presumed aggressiveness and likelihood of cancer recurrence. Oncotype DX (ODX) and other gene expression tests have allowed for distinguishing the more aggressive ER+ BCa requiring adjuvant chemotherapy from the less aggressive cancers benefiting from hormonal therapy alone. However these tests are expensive, tissue destructive and require specialized facilities. Interestingly BCa grade has been shown to be correlated with the ODX risk score. Unfortunately Bloom-Richardson (BR) grade determined by pathologists can be variable. A constituent category in BR grading is tubule formation. This study aims to develop a deep learning classifier to automatically identify tubule nuclei from whole slide images (WSI) of ER+ BCa, the hypothesis being that the ratio of tubule nuclei to overall number of nuclei (a tubule formation indicator - TFI) correlates with the corresponding ODX risk categories. This correlation was assessed in 7513 fields extracted from 174 WSI. The results suggests that low ODX/BR cases have a larger TFI than high ODX/BR cases (p < 0.01). The low ODX/BR cases also presented a larger TFI than that obtained for the rest of cases (p < 0.05). Finally, the high ODX/BR cases have a significantly smaller TFI than that obtained for the rest of cases (p < 0.01). |
format | Online Article Text |
id | pubmed-5013328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-50133282016-09-12 Automated Tubule Nuclei Quantification and Correlation with Oncotype DX risk categories in ER+ Breast Cancer Whole Slide Images Romo-Bucheli, David Janowczyk, Andrew Gilmore, Hannah Romero, Eduardo Madabhushi, Anant Sci Rep Article Early stage estrogen receptor positive (ER+) breast cancer (BCa) treatment is based on the presumed aggressiveness and likelihood of cancer recurrence. Oncotype DX (ODX) and other gene expression tests have allowed for distinguishing the more aggressive ER+ BCa requiring adjuvant chemotherapy from the less aggressive cancers benefiting from hormonal therapy alone. However these tests are expensive, tissue destructive and require specialized facilities. Interestingly BCa grade has been shown to be correlated with the ODX risk score. Unfortunately Bloom-Richardson (BR) grade determined by pathologists can be variable. A constituent category in BR grading is tubule formation. This study aims to develop a deep learning classifier to automatically identify tubule nuclei from whole slide images (WSI) of ER+ BCa, the hypothesis being that the ratio of tubule nuclei to overall number of nuclei (a tubule formation indicator - TFI) correlates with the corresponding ODX risk categories. This correlation was assessed in 7513 fields extracted from 174 WSI. The results suggests that low ODX/BR cases have a larger TFI than high ODX/BR cases (p < 0.01). The low ODX/BR cases also presented a larger TFI than that obtained for the rest of cases (p < 0.05). Finally, the high ODX/BR cases have a significantly smaller TFI than that obtained for the rest of cases (p < 0.01). Nature Publishing Group 2016-09-07 /pmc/articles/PMC5013328/ /pubmed/27599752 http://dx.doi.org/10.1038/srep32706 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Romo-Bucheli, David Janowczyk, Andrew Gilmore, Hannah Romero, Eduardo Madabhushi, Anant Automated Tubule Nuclei Quantification and Correlation with Oncotype DX risk categories in ER+ Breast Cancer Whole Slide Images |
title | Automated Tubule Nuclei Quantification and Correlation with Oncotype DX risk categories in ER+ Breast Cancer Whole Slide Images |
title_full | Automated Tubule Nuclei Quantification and Correlation with Oncotype DX risk categories in ER+ Breast Cancer Whole Slide Images |
title_fullStr | Automated Tubule Nuclei Quantification and Correlation with Oncotype DX risk categories in ER+ Breast Cancer Whole Slide Images |
title_full_unstemmed | Automated Tubule Nuclei Quantification and Correlation with Oncotype DX risk categories in ER+ Breast Cancer Whole Slide Images |
title_short | Automated Tubule Nuclei Quantification and Correlation with Oncotype DX risk categories in ER+ Breast Cancer Whole Slide Images |
title_sort | automated tubule nuclei quantification and correlation with oncotype dx risk categories in er+ breast cancer whole slide images |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013328/ https://www.ncbi.nlm.nih.gov/pubmed/27599752 http://dx.doi.org/10.1038/srep32706 |
work_keys_str_mv | AT romobuchelidavid automatedtubulenucleiquantificationandcorrelationwithoncotypedxriskcategoriesinerbreastcancerwholeslideimages AT janowczykandrew automatedtubulenucleiquantificationandcorrelationwithoncotypedxriskcategoriesinerbreastcancerwholeslideimages AT gilmorehannah automatedtubulenucleiquantificationandcorrelationwithoncotypedxriskcategoriesinerbreastcancerwholeslideimages AT romeroeduardo automatedtubulenucleiquantificationandcorrelationwithoncotypedxriskcategoriesinerbreastcancerwholeslideimages AT madabhushianant automatedtubulenucleiquantificationandcorrelationwithoncotypedxriskcategoriesinerbreastcancerwholeslideimages |